FindTrial
Sign In

Genetics and clinical profile of patients with 11-Beta hydroxylase deficiency

Clinical, Biochemical and Genetic profile of Patients with Congenital Adrenal Hyperplasia due to 11-βHydroxlase deficiency.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/10/021495
Enrollment
20
Registered
2019-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E250- Congenital adrenogenital disordersassociated with enzyme deficiency

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Congenital adrenal hyperplasia due to 11-βhydroxylase deficiency.

Exclusion criteria

Exclusion criteria: 1)Patients with clinical characteristics of 11-β hydroxylase deficiency withoutconfirmed genetic diagnosis. 2)Inadequate Biochemical data.

Design outcomes

Primary

MeasureTime frame
clinical and biochemical profile of patients with 11-Beta hydroxylasedeficiencyTimepoint: 1 year—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactAnurag Ranjan Lila

Seth G S Medical College and KEM Hospital.

anuraglila@gmail.com9323065346

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026